Results 241 to 250 of about 162,477 (300)
A meta-analysis on racial disparity in administration of tissue plasminogen activator (tPA) in stroke patients. [PDF]
Larik MO, Bhattarai P.
europepmc +1 more source
Pulmonary vascular disease in patients with single ventricular heart disease is a significant source of morbidity and mortality. Utilizing an integrated investigative platform that included a novel ovine Glenn model, we demonstrate early pulmonary vascular endothelial dysfunction with the initiation of the nonpulsatile pulmonary blood flow that ...
Jonathan Hyde +15 more
wiley +1 more source
Correlation between subretinal tissue plasminogen activator and air injection rates with pressure in a retina mimicking model. [PDF]
Kim NH, Lee M, Chung H, Kim HC, Lee H.
europepmc +1 more source
ABSTRACT Background and Aims Marfan Syndrome (MFS) is a hereditary connective tissue disorder with severe cardiovascular complications, including aortic aneurysms and dissections. Current therapies, such as beta‐blockers, have limitations in preventing disease progression.
Hashim Mohamed Siraj +9 more
wiley +1 more source
Tissue Plasminogen Activator in Acute Cardiac Arrest. [PDF]
Acharya I, DeBoer SR, Haas CJ.
europepmc +1 more source
The epidemiology and pathogenesis of uterine fibroids
Abstract Uterine fibroids, or leiomyomas, are the most common benign tumors of the female reproductive tract, ultimately affecting a majority of women worldwide, primarily during their reproductive years. While their origin appears genetic, manifesting in monoclonal tumors, diverse features and mechanisms contribute to their growth and further ...
Malcolm G. Munro +2 more
wiley +1 more source
Intravitreal tissue plasminogen activator in submacular haemorrhage
Singh Preetam +5 more
doaj
Extracellular Vesicles in Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities
The role of extracellular vesicles (EVs) in the progression of nonalcoholic fatty liver disease (NAFLD). Donor cells release EVs containing various molecules such as cholesterol, ceramide, sphingomyelin, miRNA, DNA, proteins, and lipids. These EVs are taken up by multiple recipient cells including Kupffer cells, adipocytes, β cells, adipose tissue ...
Yunsheng Dong +12 more
wiley +1 more source

